PeptideDB

KPLH1130 906669-07-6

KPLH1130 906669-07-6

CAS No.: 906669-07-6

KPLH1130 is a specific inhibitor of pyruvate dehydrogenase kinase (PDK) that blocks macrophage polarization and reduces
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

KPLH1130 is a specific inhibitor of pyruvate dehydrogenase kinase (PDK) that blocks macrophage polarization and reduces inflammatory responses. KPLH1130 improves glucose tolerance in high-fat diet-fed mice.

Physicochemical Properties


Molecular Formula C15H13N3O3
Molecular Weight 283.282023191452
Exact Mass 283.095
CAS # 906669-07-6
PubChem CID 135487465
Appearance Off-white to gray solid powder
LogP 2.2
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 2
Heavy Atom Count 21
Complexity 432
Defined Atom Stereocenter Count 0
SMILES

O=C1N(C2C=CC(C)=CC=2)C(C2C(O)=CC(O)=CC=2)=NN1

InChi Key UUTBMTOBGXJTLN-UHFFFAOYSA-N
InChi Code

InChI=1S/C15H13N3O3/c1-9-2-4-10(5-3-9)18-14(16-17-15(18)21)12-7-6-11(19)8-13(12)20/h2-8,19-20H,1H3,(H,17,21)
Chemical Name

3-(2,4-dihydroxyphenyl)-4-(4-methylphenyl)-1H-1,2,4-triazol-5-one
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Pyruvate Dehydrogenase Kinase Is a Metabolic Checkpoint for Polarization of Macrophages to the M1 Phenotype. Front Immunol. 2019 May 7;10:944.


Solubility Data


Solubility (In Vitro) DMSO : ~135 mg/mL (~476.56 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.25 mg/mL (7.94 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 22.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.5301 mL 17.6504 mL 35.3008 mL
5 mM 0.7060 mL 3.5301 mL 7.0602 mL
10 mM 0.3530 mL 1.7650 mL 3.5301 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.